Recent Updates
Recently added Catalysts
NMTC Positive Sentiment Score: 60/100

NeuroOne to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

Key Takeaway: NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) will report its financial results for the fiscal fourth quarter and year ended September 30, 2024, on December 17, 2024. The company will host an investor conference call at 9:00 a.m. Eastern Time to discuss the results, provide a corporate update, and engage in a Q&A session. NeuroOne aims to improve surgical care for patients with various neurological disorders through innovative solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • NeuroOne is focused on improving surgical care options for neurological disorders.
  • The upcoming financial results may indicate progress and successful fiscal management.
  • The investor call suggests transparency and openness to stakeholder engagement.

Full Press Release Details

EDEN PRAIRIE, Minn., Dec. 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for the fiscal fourth quarter and year ended September 30, 2024, before market open on December 17, 2024.
Management will host an investor conference call and webcast at 9:00 a.m. Eastern time on Tuesday, December 17, 2024 to discuss the Company’s fourth quarter and fiscal year 2024 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following infomaiton:
Fourth Quarter and Fiscal 2024 Earnings Conference Call
Date: Tuesday, December 17, 2024
Time: 9:00 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 603219
Webcast: NMTC Fourth Quarter and Fiscal 2024 Earnings Conference Call
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through December 31, 2024. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 51728. A webcast replay will also be available using the webcast link above through December 17, 2025.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
MZ Group – MZ North America

Tags

NeuroOne Medical Technologies
Report Fourth Quarter

Frequently Asked Questions

When will NeuroOne release its Q4 financial results?

NeuroOne will release its Q4 financial results on December 17, 2024.

What time is the investor conference call on December 17?

The investor conference call is at 9:00 a.m. Eastern time.

How can I participate in the earnings conference call?

Dial 888-506-0062 in the U.S. or 973-528-0011 internationally.

Is there a playback option for the conference call?

Yes, a playback will be available until December 31, 2024.

What conditions does NeuroOne aim to treat?

NeuroOne targets neurological disorders including epilepsy and Parkinson's disease.

Last updated: Dec 4, 2024